Theranostic system for cancer by the combination of supramolecular nanocarriers with optical technology

点击翻译按钮获取中文摘要

Enhancing its function and maximizing the accumulation efficiency, we advanced our developed supramolecular drug delivery system (DDS), resulted in the creation of light-activating supramolecular devices. Combining them with state-of-the-art optical technology, we have developed a next-generation theranostic system that can be applied to any sites in the body. Photodynamic therapy using the novel supramolecular DDS-type photosensitizers corresponds to highly selective treatment for tumors, including undetectable micro-lesions without any damage to surrounding normal tissues.